ARD & RMD Open

@ARD_BMJ

Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official journals. High quality, peer reviewed research.

rmdopen.bmj.com
Vrijeme pridruživanja: travanj 2010.

Tweetovi

Blokirali ste korisnika/cu @ARD_BMJ

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ARD_BMJ

  1. prije 22 sata

    We're delighted to announce that RMD Open has been accepted for indexing by MEDLINE! Congratulations to the editorial team and thanks to our authors and reviewers for the high quality of published articles. Discover all content at

    Poništi
  2. 5. velj

    If you haven’t had a chance to read the - 2019 update - for the management of take a moment to do so now:

    Poništi
  3. 3. velj

    VEDERA trial: Compared with rates reported with 1st-line TNFi+MTX vs MTX-T2T no larger effect seen in very . Neither strategy conferred remission in the majority of patients although confirmed local suppression.

    Poništi
  4. 31. sij

    Pragmatic RCT of early etanercept and MTX vs. MTX with delayed etanercept in : the VEDERA trial shows some clinically relevant differences (14%), but not a large effect size in with early etanercept (30%)

    Poništi
  5. 29. sij

    Don’t forget to submit your abstracts before the 31st of Jan deadline! Accepted abstracts are published in a special ARD supplement. Keep up to date with the latest Annual annual congress news here

    Poništi
  6. 28. sij

    Check our podcast on one of the highlights from : results of next promising new treatments in & with & Dr Atul Deodhar

    Poništi
  7. 27. sij

    Re-defining axial using a latent class/ transition analysis approach. Of the 3 entities identified, a large % of those 'at risk' never develop the disease at 5-years. Important implications to prevent overdiagnosis

    Poništi
  8. 27. sij

    New recommendations for the management of with disease-modifying antirheumatic drugs: 2019 update

    Poništi
  9. 23. sij

    We're delighted that RMD Open is now indexed by MEDLINE! (NLM ID: 101662038) Congratulations to the editorial team and thanks to our authors and reviewers for helping us to publish high quality content. Explore the content archive at

    Poništi
  10. 15. sij

    Long-term follow-up after cessation of immune checkpoint inhibitors (ICI) reveals that ICI-induced inflammatory arthritis persists to be active up to 24 months. Full paper here 👉🏻

    Poništi
  11. 10. sij

    Lay summary: Risk of joint surgery is increased in people with psoriatic arthritis

    Poništi
  12. 10. sij

    Lay summary: Standardisation is needed for sick leave and disability rules for people with RA

    Poništi
  13. 10. sij

    Lay summary: TNF inhibitors can be used after JAK inhibitors

    Poništi
  14. 10. sij

    Lay summary: ANA status is a critical first step for diagnosing Lupus

    Poništi
  15. 10. sij

    Lay summary: Link between fatigue and brain-reacting autoantibodies in Lupus

    Poništi
  16. 10. sij

    Lay summary: Quality of life is dependent on treatment of both joint and skin symptoms in PsA

    Poništi
  17. 31. pro 2019.

    Listen to our new podcast from the with Eric Morand about in - the -2 study - whilst preparing for the turn of the year. 🎆 To : To the paper:

    Poništi
  18. 27. pro 2019.

    Germline genetic patterns underlying across familial , systemic erythematosus and primary ’s syndrome highlight T cell-initiated

    Poništi
  19. 27. pro 2019.

    Single-cell RNA-seq analysis identifies meniscus progenitors and reveals the progression of meniscus degeneration. CD146+ meniscus cells have potential in meniscus tissue engineering

    Poništi
  20. 26. pro 2019.

    IFN-alpha kinoid significantly reduced the IFN gene signature in patients. The clinical coprimary endpoint was not met, but some secondary endpoints were achieved, notably attainment of LLDAS and steroid tapering.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·